Lyn Baranowski

New York New York United States; New York United States; United States
investor type
Angel Investors
stage focus
Seed Round
Lyn Baranowski joined Melinta Therapeutics in September 2013 as Senior Vice President, Corporate Development and Strategy, bringing to the company her deep life sciences industry experience spanning biotech, pharmaceuticals and venture capital. ...
Show more
Relevant investments:
Company
Cost
Round
  • Super company
    Billion
  • Foundersuite
    Million
    Seed A
  • Active Inv
    13 000
    Round Best
Show more